Monoclonal antibodies (mAbs) have varied therapeutic uses. It is possible to create a mAb that binds specifically to almost any extracellular target, such as cell surface proteins and cytokines. They can be used to render their target ineffective (e.g. by preventing receptor binding),[1] to induce a specific cell signal (by activating receptors),[1] to cause the immune system to attack specific cells, or to bring a drug to a specific cell type (such as with radioimmunotherapy which delivers cytotoxic radiation).
Major applications include cancer, autoimmune diseases, asthma, organ transplants, blood clot prevention, and certain infections.
^ abYao S, Zhu Y, Chen L (February 2013). "Advances in targeting cell surface signalling molecules for immune modulation". Nature Reviews. Drug Discovery. 12 (2): 130–146. doi:10.1038/nrd3877. PMC 3698571. PMID 23370250.
and 23 Related for: Monoclonal antibody therapy information
Monoclonalantibodies (mAbs) have varied therapeutic uses. It is possible to create a mAb that binds specifically to almost any extracellular target,...
A monoclonalantibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent...
nomenclature of monoclonalantibodies is a naming scheme for assigning generic, or nonproprietary, names to monoclonalantibodies. An antibody is a protein...
"humanization" is usually applied to monoclonalantibodies developed for administration to humans (for example, antibodies developed as anti-cancer drugs)...
Antibodytherapy may refer to several different uses of antibodies for the treatment of medical conditions. Monoclonalantibodytherapy Oligoclonal antibody...
A bispecific monoclonalantibody (BsMAb, BsAb) is an artificial protein that can simultaneously bind to two different types of antigen or two different...
controlled by interruption of the complement cascade. Particular monoclonalantibodies, discussed later in the article, have proven efficacy in many cases...
Rituximab, sold under the brand name Rituxan among others, is a monoclonalantibody medication used to treat certain autoimmune diseases and types of...
HuCAL standing for Human Combinatorial Antibody Library and being a technology used to generate monoclonalantibodies. Otilimab is directed against the...
Passive antibodytherapy, also called serum therapy, is a subtype of passive immunotherapy that administers antibodies (same as immunoglobin) to target...
COVID-19 antibody drug was paused due to lack of efficacy against the emerging omicron variant. A second COVID-19 monoclonalantibodytherapy (bebtelovimab)...
Zevalin, is a monoclonalantibody radioimmunotherapy treatment for non-Hodgkin's lymphoma. The drug uses the monoclonal mouse IgG1 antibody ibritumomab...
In immunology, antiserum is a blood serum containing antibodies (either monoclonal or polyclonal) that is used to spread passive immunity to many diseases...
therapy is a targeted drug delivery method that involves the use of liposomes (artificial lipid bilayer vesicles) coupled with monoclonalantibodies to...
(18F) labeling of antibodies, which allows for positron emission tomography (PET) imaging of cancer. Targeted monoclonalantibodytherapy is employed to...
was the first monoclonalantibody to be approved for use in animals in the European Union. "Zoetis earns license for Cytopoint skin therapy". Veterinary...
antiserum therapy by immunoglobulins: immunoglobulin therapy by monoclonalantibodies: monoclonalantibodytherapy by urine: urine therapy (some scientific...
the remainder of life. The cost of treatment with a typical monoclonalantibodytherapy for relatively common indications is generally in the range of...
apoptosis. Numbers of eosinophils in blood are rapidly reduced monoclonalantibodytherapy – e.g., mepolizumab or reslizumab against IL-5, prevents eosinophilopoiesis...
Naked monoclonalantibodies are antibodies without added elements. Most antibodytherapies use this antibody type. Conjugated monoclonalantibodies are...
Global Information